Skip to main content
Earnings Labs
Zentalis Pharmaceuticals, Inc. logo

Zentalis Pharmaceuticals, Inc. (ZNTL)

NASDAQ·Healthcare·Biotechnology

$2.02

+2.02%

Mkt Cap $168.00M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (15 analysts)

$8.33

Range $5.00 – $10.00

Implied Upside

+313.4%

Consensus $8.33 vs current $2.02